P2RX4 and Alzheimer disease: In contrast, P2RX4, a purinergic receptor that is likely to be involved in shifting microglia towards a pro-inflammatory phenotype (Calovi et al., 2019) or myelin phagocytosis (Zabala et al., 2018) had an increased abundance in both AD models.